Alternative‐splicing defects in cancer: splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
LM Urbanski, N Leclair… - Wiley Interdisciplinary …, 2018 - Wiley Online Library
Defects in alternative splicing are frequently found in human tumors and result either from
mutations in splicing‐regulatory elements of specific cancer genes or from changes in the …
mutations in splicing‐regulatory elements of specific cancer genes or from changes in the …
The double dealing of cyclin D1
G Tchakarska, B Sola - Cell cycle, 2020 - Taylor & Francis
The cell cycle is tightly regulated by cyclins and their catalytic moieties, the cyclin-dependent
kinases (CDKs). Cyclin D1, in association with CDK4/6, acts as a mitogenic sensor and …
kinases (CDKs). Cyclin D1, in association with CDK4/6, acts as a mitogenic sensor and …
[HTML][HTML] Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation
J Wang, W Su, T Zhang, S Zhang, H Lei, F Ma… - Cell Death & …, 2023 - nature.com
Abstract Cyclin D1 (CCND1), a crucial mediator of cell cycle progression, possesses many
mutation types with different mutation frequencies in human cancers. The G870A mutation is …
mutation types with different mutation frequencies in human cancers. The G870A mutation is …
[HTML][HTML] CHD1 loss alters AR binding at lineage-specific enhancers and modulates distinct transcriptional programs to drive prostate tumorigenesis
MA Augello, D Liu, LD Deonarine, BD Robinson… - Cancer Cell, 2019 - cell.com
Deletion of the gene encoding the chromatin remodeler CHD1 is among the most common
alterations in prostate cancer (PCa); however, the tumor-suppressive functions of CHD1 and …
alterations in prostate cancer (PCa); however, the tumor-suppressive functions of CHD1 and …
[HTML][HTML] Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles
DT Hoang, KA Iczkowski, D Kilari, W See… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …
cause of cancer-related death for American men due to a subset of patients progressing to …
Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression
ABSTRACT AR (androgen receptor) signaling is crucial for the development and
maintenance of the prostate as well as the initiation and progression of prostate cancer …
maintenance of the prostate as well as the initiation and progression of prostate cancer …
[HTML][HTML] Function, clinical application, and strategies of Pre-mRNA splicing in cancer
C Di, Syafrizayanti, Q Zhang, Y Chen, Y Wang… - Cell Death & …, 2019 - nature.com
Pre-mRNA splicing is a fundamental process that plays a considerable role in generating
protein diversity. Pre-mRNA splicing is also the key to the pathology of numerous diseases …
protein diversity. Pre-mRNA splicing is also the key to the pathology of numerous diseases …
[HTML][HTML] Prostate cancer stem cells: the role of androgen and estrogen receptors
E Di Zazzo, G Galasso, P Giovannelli, M Di Donato… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Prostate cancer is one of the most commonly diagnosed cancers in men, and androgen
deprivation therapy still represents the primary treatment for prostate cancer patients. This …
deprivation therapy still represents the primary treatment for prostate cancer patients. This …
RB loss promotes prostate cancer metastasis
C Thangavel, E Boopathi, Y Liu, A Haber, A Ertel… - Cancer research, 2017 - AACR
RB loss occurs commonly in neoplasia but its contributions to advanced cancer have not
been assessed directly. Here we show that RB loss in multiple murine models of cancer …
been assessed directly. Here we show that RB loss in multiple murine models of cancer …
[HTML][HTML] Multiple gene aberrations and breast cancer: lessons from super-responders
JJ Wheler, JT Atkins, F Janku, SL Moulder, R Yelensky… - BMC cancer, 2015 - Springer
Background The presence of multiple molecular aberrations in patients with breast cancer
may correlate with worse outcomes. Case Presentations We performed in-depth molecular …
may correlate with worse outcomes. Case Presentations We performed in-depth molecular …